IP Library Granted Patent US 7,390,647
Granted Patent B2
US 7,390,647 · App. 10/544,103 · Granted Jun 24, 2008

Method for producing chiral α-hydroxycarboxylic crystalline acids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,390,647
App. No.
10/544,103
Granted
Jun 24, 2008
Kind
B2
Abstract

The invention relates to a method for producing chiral α-hydroxycarboxylic crystalline acids consisting in transforming cyanhydrins (R) or (S) into α-hydroxycarboxylic acids (R) or (S), respectively by enzymatic hydrolysis in the presence of Rhodococcus erythropolis NCIMB 11540.

Claims (11)

1. A method for producing chiral α-hydroxycarboxylic acids, which comprises converting (R)- or (S)-cyanohydrins by enzymatic hydrolysis in the presence of Rhodococcus erythropolis NCIMB 11540 into the conjugate (R)- or (S)-α-hydroxycarboxylic acids.

2. The method as claimed in claim 1 , characterized in that (R)- or (S)-cyanohydrins are used as starting materials which are obtained by enzymatic or chemically catalyzed addition of a cyanide group to the corresponding aliphatic, aromatic or heteroaromatic aldehydes or ketones.

3. The method as claimed in claim 1 , characterized in that (R)- or (S)-cyanohydrins of the formula

where R1 and R2 independently of one another are H, a C 1 -C 6 -alkyl or C 1 -C 6 -alkenyl radical which is optionally monosubstituted or polysubstituted by substituents inert under the reaction conditions, or a phenyl radical which is optionally monosubstituted or polysubstituted by substituents inert under the reaction conditions, with the proviso that R1 and R2 are not both H, are used.

4. The method as claimed in claim 1 , characterized in that use is made of the microorganism Rhodococcus erythropolis NCIMB 11540 in the form of ground cells, immobilized cells, lyophilized cells, or “resting cells”.

5. The method as claimed in claim 1 , characterized in that the microorganism Rhodococcus erythropolis NCIMB 11540 is suspended in an aqueous medium and the resultant suspension is admixed with the corresponding chiral cyanohydrin in the presence of a solubilizer as cosolvent.

6. The method as claimed in claim 5 , characterized in that, as solubilizer, use is made of organic solvents, surfactants, or phase-transfer catalysts.

7. The method as claimed in claim 6 , characterized in that, as organic solvent, use is made of DMSO, DMF, C 1 -C 6 -alcohols, TMBE or mixtures thereof.

8. The method as claimed in claim 5 , characterized in that the cosolvent fraction is between 0.5 and 20% by volume, based on the total volume of the reaction solution.

9. The method as claimed in claim 1 , characterized in that the pH of the reaction mixture is between 4.5 and 11.

10. The method as claimed in claim 1 , characterized in that the hydrolysis is carried out at a temperature between 10 and 60° C.

Assignments (4)
RELEASE (REEL 032424 / FRAME 0001) Recorded Sep 28, 2017
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: DSM FINE CHEMICALS AUSTRIA NFG GMBH & COKG
Reel/Frame 044037/0879 →
NOTICE OF SUCCESSION OF AGENCY FOR PATENT SECURITY INTEREST PREVIOUSLY RECORDED AT REEL/FRAME (032424/0001) Recorded Jul 12, 2017
From: UBS AG, STAMFORD BRANCH, AS PRIOR AGENT
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS SUCCESSOR AGENT
Reel/Frame 043165/0987 →
SECURITY INTEREST Recorded Mar 11, 2014
From: DSM FINE CHEMICALS AUSTRIA NFG GMBH & COKG
To: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
Reel/Frame 032424/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2005
From: GRIENGL, HERFRIED; OSPRIAN, INGRID; SCHOEMAKER, HANS; REISINGER, CHRISTOPH; SCHWAB, HELMUT
To: DSM FINE CHEMICALS AUSTRIA NFG GMBH &CO KG
Reel/Frame 017291/0443 →